
Safe Bulkers (NYSE: SB) delivered its strongest quarter of the current cycle. Adjusted earnings were $0.31 per share on revenue of $91.03 million for the September quarter. Earnings grew 158.3% year over year and revenue grew 24.6%. There was no consensus estimate or whisper number to measure against, so the quarter has to be judged on its trajectory. That trajectory is clearly upward. Adjusted EPS has climbed from $0.14 in the fourth quarter of 2025 to $0.18, $0.28 and now $0.31. The board lifted the quarterly dividend for a third straight time, to $0.09 from $0.075. The central tension is that record results arrived alongside a noticeably more guarded view of 2027. Management now frames the supply-demand balance as turning unfavorable beyond the next few quarters.
The quality of the quarter holds up, with a few caveats. GAAP EPS of $0.35 included a $6.8 million gain on the sale of the Pedhoulas Commander and Xenia. The adjusted figure strips that out, along with a $1.4 million foreign-currency loss, leaving adjusted net income of $34.0 million versus $13.9 million a year ago.
The engine was rates rather than volume:
The sequential picture is less dramatic. TCE rose only about 3% from $20,642 in Q2, and adjusted EPS added three cents after a ten-cent jump the prior quarter. Growth is still positive, but the steep part of the recovery appears to be behind the company.
One data conflict is worth flagging. The call materials cite third-quarter adjusted EBITDA of $63.8 million. The press release reconciliation shows $53.8 million, up from $50.3 million in Q2 and $36.1 million a year earlier. The release figure ties to the reconciliation table and should be treated as the reliable number.
Costs moved the wrong way year over year:
The call preserved a credible near-term story. The CEO said he is optimistic about the next two to three quarters. A Capesize, the Pelopidas, was fixed forward at $37,500 per day plus a scrubber premium starting in early 2027. Management also noted that Capesize rates for 2027 are being quoted well above $30,000. Contracted revenue rose to roughly $183 million from about $154 million in Q2.
Bears have legitimate ammunition, though:
The balance sheet changed meaningfully:
Market context is limited. No investor sentiment readings or current price were supplied. Shares opened at $7.98 after the July report, comfortably above the 200-day moving average, now at $7.12. The September placement was priced at €6.70 per share, which marks the level at which institutional buyers were willing to commit fresh capital. Investors should watch whether the stock holds above its longer-term average as the market weighs record earnings against the cooler 2027 framing.
The bottom line is that Safe Bulkers converted a strong charter market into record adjusted earnings, a rising dividend and a fortified balance sheet. Sequential momentum is flattening, though. Management's own outlook points to a less favorable supply-demand balance in 2027, a year in which most of the fleet remains uncontracted. Near-term earnings power looks secure. The durability of these returns beyond the next few quarters is now the open question.
This earnings review was originally published on Earnings Whispers.
This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.
| Nov-10 | |
| Nov-09 | |
| Nov-09 | |
| Nov-03 | |
| Oct-23 | |
| Oct-02 | |
| Sep-10 | |
| Aug-27 | |
| Jul-28 | |
| Jul-28 | |
| Jul-22 | |
| Jul-01 | |
| Jun-22 | |
| Jun-18 | |
| Jun-17 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite